These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5576122)

  • 1. [Note on the treatment of parkinsonism with amantadine].
    Serratrice G
    Mars Med; 1971; 108(3):241-2. PubMed ID: 5576122
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of Parkinsonism with amantadine hydrochloride.
    Pa Med; 1971 Apr; 74(4):54-5. PubMed ID: 5147644
    [No Abstract]   [Full Text] [Related]  

  • 3. [Amantadine for parkinsonism].
    Flatberg P
    Tidsskr Nor Laegeforen; 1970 May; 90(10):1101-2. PubMed ID: 5450047
    [No Abstract]   [Full Text] [Related]  

  • 4. [Amantadine treatment in parkinsonism].
    Holmsen R
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2118-9. PubMed ID: 4773984
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical results of the intravenous administration of amantadine in patients with parkinsonism].
    Caliri F; Di Rosa AE; Meduri M; Megna G; Musolino R; Scuderi D
    Minerva Med; 1971 Oct; 62(82):3994-6. PubMed ID: 5125062
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of parkinsonism with viregyt (amantadine)].
    Pryszmont M; Jankowicz E; Eljasz L; Slizewski M; Wiśniewska Z
    Wiad Lek; 1974 Aug; 27(15):1371-5. PubMed ID: 4418066
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-time therapy of Parkinsonism with amantadine sulfate. Reply to L.W. Diehl: "Nil nocere. Adverse effects of amantadine therapy of parkinsonism"].
    Fünfgeld EW
    Munch Med Wochenschr; 1972 Jun; 114(22):1064-5. PubMed ID: 5068021
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term therapy of parkinsonism using amantadine salts].
    Damielczyk W; Struppler A; Velho-Groneberg P; Clemens R; Diehl LW
    Med Welt; 1976 Apr; 27(14):669-75. PubMed ID: 1263820
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the treatment of Parkinson's disease with intravenous administration of amantadine (77 cases)].
    Fasano VA; Urciuoli R; Broggi G
    Minerva Med; 1971 Oct; 62(82):3968-70. PubMed ID: 5125055
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nil nocere. Adverse effects of amantadine therapy of parkinsonism. Summary to E.W. Fünfgeld: "Long-time therapy of parkinsonism with amantadine sulfate" and to G. Völler: "Amantadine therapy of parkinsonism"].
    Diehl LW
    Munch Med Wochenschr; 1972 Jun; 114(22):1068. PubMed ID: 5068023
    [No Abstract]   [Full Text] [Related]  

  • 11. Amantadine hydrochloride in the treatment of parkinsonism: a placebo-controlled double-blind study.
    Freedman BE; Getz E; MacGregor JM; Ames FR
    S Afr Med J; 1971 Apr; 45(16):435-7. PubMed ID: 4932339
    [No Abstract]   [Full Text] [Related]  

  • 12. Renaissance of amantadine in the treatment of Parkinson's disease.
    Blanchet PJ; Metman LV; Chase TN
    Adv Neurol; 2003; 91():251-7. PubMed ID: 12442683
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of amantadine in the treatment of parkinsonism].
    D'Andrea F; De Divitiis E; Signorelli CD; Cerillo A
    Minerva Med; 1971 Oct; 62(82):3952-4. PubMed ID: 5125049
    [No Abstract]   [Full Text] [Related]  

  • 14. [The additive effect of amantadine hydrochloride (Symmetrel) on parkinsonian patients receiving levodopa treatment (author's transl)].
    Shiozawa R; Kase M; Kuroiwa Y; Narabayashi H; Nishitani Y; Ohmoto T; Toyokura Y; Uono K
    No To Shinkei; 1981 Mar; 33(3):301-9. PubMed ID: 7018522
    [No Abstract]   [Full Text] [Related]  

  • 15. The posology of amantadine: a note of caution.
    Ing TS; Daugirdas JT; Soung LS
    JAMA; 1980 May; 243(18):1844-5. PubMed ID: 7365963
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of amantadine in parkinsonism].
    Crudeli R; Candia O
    Minerva Med; 1971 Oct; 62(82):3963-4. PubMed ID: 5125053
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of Parkinson's syndrome].
    Fortschr Med; 1982 Jun; 100(24):1172. PubMed ID: 7106681
    [No Abstract]   [Full Text] [Related]  

  • 18. [On some effects of amantadine in muscle potentials in parkinsonism].
    Laterza A; Jandolo B; Sinibaldi L
    Minerva Med; 1971 Oct; 62(82):3987-9. PubMed ID: 5125060
    [No Abstract]   [Full Text] [Related]  

  • 19. The continued use of amantadine hydrochloride in parkinsonism.
    Appleton DB; Eadie MJ; Sutherland JM
    Med J Aust; 1971 Oct; 2(14):707-9. PubMed ID: 4939890
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic effects of amantadine hydrochloride on manifestations of parkinsonism].
    Espadaler Medina JM; Olivella Rius J; Ruscadella Nadal J
    Rev Esp Otoneurooftalmol Neurocir; 1969-1970; 28(164):236-46. PubMed ID: 5398580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.